Company: Eli Lilly and Company

(Reuters) - Drugmaker Eli Lilly and Co's experimental drug to treat type 2 diabetes met the main goal of a mid-stage trial to test its effect on blood pressure and heart rate.

DRUG KILLED: Roche has ended all testing of experimental drug dalcetrapib, meant to raise good cholesterol, after a late-stage study showed it didn't help patients.

A second experimental cholesterol medicine in a once-promising class of drugs meant to replace blockbusters such as Lipitor has failed in testing, casting doubt on whether any of the drugs will ever make it to pharmacies.

CHICAGO/WASHINGTON (Reuters) - The U.S. government will help drug companies find treatments for a host of diseases through a new collaboration in which researchers will test experimental drugs provided by manufacturers.

CHICAGO/WASHINGTON (Reuters) - The U.S. government will help drug companies find treatments for a host of diseases through a new collaboration in which researchers will test experimental drugs provided by manufacturers.

(Reuters) - Prosecutors in Connecticut on Thursday said two people were arrested for participating in the late-night break-in two years ago of a warehouse owned by drugmaker Eli Lilly & Co and the theft of more than $70 million in prescription drugs.

Three pharmaceutical giants are unlocking their freezers to see if government-funded scientists can reinvent some of their old drugs.

Authorities have made arrests in the 2010 theft of about $80 million in prescription drugs from a Connecticut warehouse, a robbery described as one of the biggest pharmaceutical heists in history, the U.S. attorney's office said Thursday.

CHICAGO (Reuters) - The U.S. government will help drug companies find treatments for a host of diseases through a new collaboration in which researchers at the National Institutes of Health will test experimental drugs provided by manufacturers.

A warning letter written by the Food & Drug Administration last week to ten companies that produce pre-workout supplements with the ingredient dimethylamyamine (DMAA) has sent shockwaves through the industry, not only to the producers of the products but to consumers who have taken them.

ImmunoGen Inc.'s fiscal third-quarter loss widened, as operating expenses rose and the cancer treatment developer took in a smaller amount of research and development support fees.

Drugmaker Bristol-Myers Squibb Co. on Thursday reported an 11.7 percent jump in first-quarter profit, as higher medicine sales and a gain from a legal settlement offset higher spending for marketing recently launched drugs.

Diabetes drug maker Amylin Pharmaceuticals Inc. said Thursday that sales of its new drug Bydureon totaled $6.9 million in the first quarter, missing analysts' estimates.

Drugmaker Bristol-Myers Squibb Co. on Thursday reported an 11.7 percent jump in first-quarter profit, as higher medicine sales and a gain from a legal settlement offset higher spending for marketing recently launched drugs.

Eli Lilly's quarterly profit fell on plunging sales of its Zyprexa schizophrenia drug, but results handily topped Wall Street forecasts, helped by strong sales of anti-depressant Cymbalta and demand for the company's animal health products.